We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » ConvaTec Recalls Fecal Management System Kits

ConvaTec Recalls Fecal Management System Kits

June 23, 2014

ConvaTec is conducting a Class I recall of its Flexi-Seal CONTROL fecal management system kits, due to a lack of FDA clearance to market the products. Customers should stop using and distributing the devices immediately, the company said.

According to a recall notice posted to the FDA website on June 20, the Skillman, N.J., devicemaker received reports of 13 negative events associated with the device between February 2013 and March of this year. The reports included 12 serious injuries and one death between Feb. 2013 and March 2014, the period during the device was distributed in the U.S.

“However, the firm did not seek FDA clearance to legally market this device through the 510(k) process,” the notice says.

Flexi-Seal CONTROL is intended for the management of fecal incontinence through collection of liquid to semi-liquid stool and the provision of prescription medications. But the device’s auto-valve feature fails to properly inflate and deflate the retention balloon in some instances, ConvaTec says.

Use of the device may lead to rectal damage, expulsion of the device and/or leakage, soiling of bed linen and incontinence pads, which in turn can lead to skin deterioration, peeling skin, raw, irritated lesions and possibly death, the devicemaker says.

ConvaTec sent an Urgent Voluntary Medical Device Recall letter to its customers on April 29, alerting them to stop using the device and quarantine kits in their possession. — Kellen Owings

Subscribe to Devices & Diagnostics Letter for complete coverage of the medical devices industry. Click here for more information.

Medical Devices Postmarket Safety

Upcoming Events

  • 13Jul

    FDA Ad and Promo Enforcement Trends: Past, Present and Future

  • 28Jul

    EU-MDR’s Growing Pains: Are You Current with the Latest Developments?

  • 28Jul

    Is Your Product a Drug or Device — and Does It Matter?: A Recent Appeals Court Decision Says It Does

  • 02Aug

    Medical Device Cybersecurity: Understand the Latest Developments

  • 03Aug

    Pharmaceutical Process Validation: Best Practices for Success

  • 10Aug

    Gene & Cell Therapy Regulation: Comparability and Other New Developments

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • FDA Provides Update on GE Healthcare’s Recall of Its Carescape R860 Ventilators

  • Gilead Resubmits NDA for Lenacapavir Following Complete Response Letter

  • FDA Warns Baby Neck Floats Used in Water Therapy Can Cause Death or Injury

  • U.S. Government Inks $3.2 Billion Contract With Pfizer-BioNTech for Vaccine Booster Campaign

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing